Coverage dated October 15, 2026 to October 16, 2026
FDA advances peptide push to White House
Headline from The Hill
Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to a government filing, which wou…
The Hill's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
WASHINGTON (AP) — U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections that have become popular among followers of Health Secretary Robert F. Kennedy Jr. and other wellness influencers.
Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to a government filing, which wou…
WASHINGTON -- U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections that have become popular among followers of Health Secretary Robert F. Kennedy Jr. and other wellness influencers.
A requested policy for adopting an alternative medicine is slotted for approval pending permission from the White House. Following the sanction of six peptide drugs from the […]
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Related updates
Separate coverage close to this update in time and subject.
